Advertisement

Topics

KCI Licensing, Inc. Company Profile

07:06 EDT 20th June 2018 | BioPortfolio

KCI’s innovative therapies make a difference in patients' lives every day. KCI’s therapies can be found helping patients recovering in all care settings. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our products are backed by a worldwide network of service and clinical support.

Contact

Phone: 1-800-275-4524


News Articles [148 Associated News Articles listed on BioPortfolio]

Zymeworks and Daiichi Sankyo Strike Second Licensing Agreement for Bispecific Antibody Platforms

Two years after entering into a licensing relationship Canada-based Zymeworks Inc. and Japanese pharma giant Daiichi Sankyo have entered into a second licensing agreement to expand immuno-oncology res...

Small-Cap Snapshot: Cara Therapeutics lands licensing deal, Revlon appoints its first female CEO

The biotech entered a licensing agreement with the largest provider of kidney dialysis in the US

Eiger expands lonafarnib licensing deal with Merck

Eiger BioPharmaceuticals has expanded a licensing agreement with Merck to cover the right to develop lonafarnib to treat Hutchinson-Gilford progeria...Read More... The post Eiger expands lonafarnib li...

Life cycle and regulatory evaluation of biosimilars

The life cycle of a biosimilar, like any biological, starts with research and development, then manufacturing, and is followed by regulatory evaluation of quality, safety and efficacy for both licensi...

vTv Therapeutics inks licensing deal for PPAR-delta program

Hot on the heels of an out-licensing deal for China, vTv Therapeutics has entered into a global agreement…

PAVmed finalizes licensing deal for Barrett's esophagus detection tech

A definitive licensing deal was completed by PAVmed for Case Western Reserve University's EsoCheck technology, a combination  -More- 

2018 China Licensing Awards Returns for Second Consecutive Year

For more information and to submit a nomination in any of the 12 award categories, visit:wjx.top/jq/20676729.aspx The China Licensing Award nominations will be submitted Read more...

Deal Making in 2012- What Next? Part 1- Licensing

Part 1:In this episode Helen Wright talks to Fintan Walton,CEO PharmaVentures, Shaun Grady, VP Strategic Partnering Business Development, AstraZeneca and Andy Richards, BioTech Entrepreneur about the ...

Drugs and Medications [0 Results]

None

PubMed Articles [39 Associated PubMed Articles listed on BioPortfolio]

Rapid DNA replication origin licensing protects stem cell pluripotency.

Complete and robust human genome duplication requires loading MCM helicase complexes at many DNA replication origins, an essential process termed origin licensing. Licensing is restricted to G1 phase ...

Scope and Nature of Pain- and Analgesia-Related Content of the United States Medical Licensing Examination (USMLE).

"The ongoing opioid crisis lies at the intersection of two substantial public health challenges-reducing the burden of suffering from pain and containing the rising toll of the harms that can result f...

Performance of candidates disclosing dyslexia with other candidates in a UK medical licensing examination: cross-sectional study.

The aim of this study was to compare performance of candidates who declared an expert-confirmed diagnosis of dyslexia with all other candidates in the Applied Knowledge Test (AKT) of the Membership of...

'A true partner around the table?' Perceptions of how to strengthen public health's contributions to the alcohol licensing process.

There are increased opportunities for public health practitioners (PHPs) in England to shape alcohol availability and reduce harms through a statutory role in licensing processes in local government. ...

Perinatal Licensing of Thermogenesis by IL-33 and ST2.

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Annual Study for Fluarix Registration

A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the v...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

A Post-Marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs ...

StaphVAX Immunogenicity in Orthopedic Implant Patients

S. aureus is the most common pathogen involved in prosthetic joint infection. StaphVAX® is a vaccine to prevent these infections, which conjugates the purified capsular polysaccharides of...

Yearly Strain Variation Study, 2009/2010

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Uni...

Companies [446 Associated Companies listed on BioPortfolio]

ProPharma Partners (UK)

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

Propharma Partners Incorporated USA

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

AllianCat Tschannen - Pharma Research & Licensing Consultants

AllianCat delivers professional support to companies in the pharmaceutical, biotechnology and chemical arena by providing services for business development and licensing. The objective is to optimize ...

Innomedica Ltd

Innomedica Ltd. is an established international business development and licensing company focused on the Life Sciences. Innomedica provides professional services to biotechnology companies in three a...

New Renaissance Institute

New Renaissance Institute® (NRI, www.newrenaissanceinstitute.com) is a privately-held for-profit interdisciplinary R&D institution based in Belmont, California. NRI has innovat...

More Information about "KCI Licensing, Inc." on BioPortfolio

We have published hundreds of KCI Licensing, Inc. news stories on BioPortfolio along with dozens of KCI Licensing, Inc. Clinical Trials and PubMed Articles about KCI Licensing, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KCI Licensing, Inc. Companies in our database. You can also find out about relevant KCI Licensing, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record